Record Dry Powder, Fewer Cheques: Why Good Businesses Still Cannot Raise

There has never been more capital pointed at India, and the number of businesses that cannot raise it has gone up, not down. EY-IVCA counted US$23.7 billion of PE/VC fundraising across 56 funds by the end of August 2026, the strongest year on record, with dry powder in India-focused alternative investment funds approaching US$100 billion. Over the same period, Tracxn data reported by Business Standard showed equity funding of US$10.9 billion across 1,253 rounds to mid-October, against 1,982 rounds a year earlier. More money, fewer cheques, larger average sizes. So if your round is stuck, the market is not short of capital. Something specific about your situation is not clearing an investment committee, and it is almost always one of five things.

Capital Is Abundant. Cheques of Your Size Are Not.

A fund's cheque size is a function of its own economics, not of your merit. A US$1 billion fund with eight investment professionals cannot write Rs 20 crore tickets. The partner time per rupee deployed does not work, and the position would be too small to move the fund even if it returned ten times. As Indian funds have got larger, that floor has risen with them. Average round size in 2026 rose to roughly US$8.6 million from US$5.1 million a year earlier, and the top ten fundraisers took nearly 36 per cent of all equity capital deployed.

The practical consequence is that a business raising Rs 15 to 40 crore is not competing with large deals for the same money. It is fishing in a different and much thinner pool: early-stage funds, family offices, HNI syndicates, sector specialists and strategic investors. Founders routinely pitch to funds whose last three deals were five times their ask, then conclude the market has rejected them. It has not. They were never in the mandate.

Investors Underwrite Your Exit, Not Your Performance.

Every institutional investor is buying an asset it has to sell. The committee question is not whether your business is good. It is who buys this stake in five to seven years, at what multiple, and with what certainty. When that answer is thin, the deal dies regardless of how the business is trading.

That question has become harder to answer. EY-IVCA recorded US$1.6 billion of exits across 17 transactions in July 2026, down 83 per cent year on year. Funds sitting on ageing portfolios and slow distributions get more conservative, not less, when they have more money to deploy. If your plan has no credible exit route, no listing path on the numbers you will actually have, no obvious strategic acquirer and no secondary buyer at a sensible price, you are asking an investor to take entry risk and exit risk at the same time. Most will decline politely and call it a timing issue.

A Good Business and a Fund-Returning Business Are Not the Same Asset.

Venture and growth funds operate on a power law. A fund returning three times gross needs a handful of positions to return the entire fund by themselves. That requires companies capable of ten times or more from entry, which in turn requires a large addressable market, a steep growth curve and a plausible path to a very large terminal value.

A business compounding revenue at 25 per cent with 18 per cent EBITDA margins and strong return on capital is an excellent asset. It is also, for most venture mandates, uninvestable. Not because it is weak, but because it cannot return a fund. That is a mandate mismatch, and founders consistently misread it as a verdict on quality.

The useful response is not to manufacture a hockey stick for the deck. It is to change the counterparty. Steadily compounding, cash-generating businesses are exactly what family offices, mezzanine and structured credit providers, promoter-friendly PE and strategic investors are looking for, and they price off cash flows rather than off terminal value fantasy.

If the Numbers Do Not Reconcile, Nothing Else Survives Diligence.

Most rounds are not lost in the pitch. They are lost four to six weeks into diligence, when three versions of the same business appear. The MIS the founder presented, the audited financials and the GST returns tell different stories. Related-party transactions move margin between group entities. A block of revenue has no supporting documentation. Receivables described as 45 days are 90 in the ledger, with a quarter of them over a year old.

None of this is necessarily improper. In founder-run businesses it is usually the residue of fifteen years of informal practice. But an investor cannot underwrite earnings it cannot verify, and once the first inconsistency appears, every other number gets re-examined. Discount rates go up. Earn-outs appear. Valuations get re-cut mid-process, which is the most common reason a founder walks away from their own fundraise.

Fix this before you go to market, not during it. Reconcile books to returns to MIS for three years, clean up intercompany flows, age the debtors honestly, and be ready to defend every adjustment you make to EBITDA.

Process Failure Looks Exactly Like Market Rejection.

The way most founder-led fundraises run guarantees a weak outcome. Investors are approached one at a time, in sequence. There is no deadline, so there is no urgency. Each conversation runs at its own pace, the first term sheet arrives with no alternative beside it, and the founder negotiates alone. Nine months in, the financials are stale, the plan has been missed, and the business has to explain a gap it created by taking too long.

Capital is priced by competition. Run a parallel process on a defined timeline, with a qualified list built around mandate fit rather than brand, a complete data room on day one, and an ask that falls out of the plan rather than preceding it. The same business, taken to market properly, routinely prices differently. Not because the story improved, but because there is more than one buyer in the room.

Before you go back out, work out which of the five is actually your problem, because the fixes are not interchangeable. A mandate mismatch needs a different investor list. A diligence problem needs six weeks of finance work before any outreach. An exit problem needs a change to the plan, or a change to the instrument, and for many profitable, steadily growing businesses the honest answer is that the next phase of growth should be funded with debt or structured capital rather than by selling equity into a market that will not price it properly. Being unable to raise equity is information. Treat it as a diagnosis, not a rejection.

Disclaimer

This article is for general information only and does not constitute financial, investment, tax, legal, or professional advice. The views expressed are for general informational purposes and should not be relied upon as a substitute for advice specific to your business or circumstances. Please seek appropriate professional advice before making any business, financial, investment, or transaction-related decision.